, Volume 35, Issue 4, pp 297–303

Islet amyloid polypeptide — a novel controversy in diabetes research

  • P. Westermark
  • K. H. Johnson
  • T. D. O'Brien
  • C. Betsholtz


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Westermark P (1972) Quantitative studies of amyloid in the islets of Langerhans. Upsala J Med Sci 77: 91–94Google Scholar
  2. 2.
    Westermark P, Grimelius L (1973) the pancreatic islet cells in insular amyloidosis in human diabetic and non-diabetic adults. Acta Path Microbiol Scand A 81: 291–300Google Scholar
  3. 3.
    Opie EL (1901) On the relation of chronic interstitial pancreatitis to the islands of Langerhans and to diabetes mellitus. J Exp Med 5: 397–428Google Scholar
  4. 4.
    Weichselbaum A, Stangl E (1901) Zur Kenntnis der feineren Veränderungen des Pankreas bei Diabetes mellitus. Wien Klin Wochenschr 14: 968–972Google Scholar
  5. 5.
    Glenner GG (1980) Amyloid deposits and amyloidosis. The β-fibrilloses. N Engl J Med 302: 1283–1292Google Scholar
  6. 6.
    Glenner GG (1980) Amyloid deposits and amyloidosis. The β-fibrilloses. N Engl J Med 302: 1333–1343Google Scholar
  7. 7.
    Westermark P (1973) Fine structure of islets of Langerhans in insular amyloidosis. Virchows Arch A 359: 1–18Google Scholar
  8. 8.
    Westermark P, Wernstedt C, Wilander E, Sletten K (1976) A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 140: 827–831Google Scholar
  9. 9.
    Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH (1987) Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA 84: 3881–3885Google Scholar
  10. 10.
    Westermark P, Wernstedt C, O'Brien TD, Hayden DW, Johnson KH (1987) Islet amyloid in type 2 diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am J Pathol 127: 414–417Google Scholar
  11. 11.
    Cooper GJS, Willis AC, Clark A, Turner RC, Sim RB, Reid KBM (1987) Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 84: 8628–8632Google Scholar
  12. 12.
    Cooper GJS, Leighton B, Dimitriadis GD et al. (1988) Amylin found in amyloid deposits in type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. Proc Natl Acad Sci USA 85: 7763–7766Google Scholar
  13. 13.
    Sanke T, Bell GI, Sample C, Rubenstein AH, Steiner DF (1988) An islet amyloid peptide is derived from an 89-amino acid pre-cursor by proteolytic processing. J Biol Chem 263: 17243–17246Google Scholar
  14. 14.
    Betsholtz C, Svensson V, Rorsman F et al. (1989) Islet amyloid polypeptide (IAPP): cDNA cloning and identification of an amyloidogenic region associated with the species-specific occurrence of age-related diabetes mellitus. Exp Cell Res 183: 484–493Google Scholar
  15. 15.
    Mosselman S, Höppener JWM, Lips CJM, Jansz HS (1989) The complete islet amyloid polypeptide precursor is encoded by two exons. FEBS Lett 247: 154–158Google Scholar
  16. 16.
    Betsholtz C, Christmanson L, Engström U et al. (1989) Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between species. FEBS Lett 251: 261–264Google Scholar
  17. 17.
    Nishi M, Chan SJ, Nagamatsu S, Bell GI, Steiner DF (1989) Conservation of the sequence of islet amyloid polypeptide in five mammals is consistent with its putative role as an islet hormone. Proc Natl Acad Sci USA 86: 5738–5742Google Scholar
  18. 18.
    Betsholtz C, Christmanson L, Engström U et al. (1990) Structure of cat islet amyloid polypeptide and identification of amino acid residues of potential significance for islet amyloid formation. Diabetes 39: 118–122Google Scholar
  19. 19.
    Nishi M, Sanke T, Nagamatsu S, Bell GI, Steiner DF (1990) Islet amyloid polypeptide. A new β-cell secretory product related to islet amyloid deposits. J Biol Chem 265: 4173–4176Google Scholar
  20. 20.
    Johnson KH, O'Brien TD, Hayden DW et al. (1988) Immunolocalization of islet amyloid polypeptide (IAPP) in pancreatic beta cells by means of peroxidase-antiperoxidase (PAP) and protein A-gold techniques. Am J Pathol 130: 1–8Google Scholar
  21. 21.
    Lukinius A, Wilander E, Westermark GT, Engström U, Westermark P (1989) Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets. Diabetologia 32: 240–244Google Scholar
  22. 22.
    Clark A, Edwards CA, Ostle LR et al. (1989) Localization of islet amyloid polypeptide in lipofuscin bodies and secretory granules of human B-cells and in islets of type-2 diabetic subjects. Cell Tissue Res 257: 179–185Google Scholar
  23. 23.
    Nishi M, Sanke T, Seino S et al. (1989) Human islet amyloid polypeptide gene: complete nucleotide sequence, chromosomal localization, and evolutionary history. Mol Endocrinol 3: 1775–1781Google Scholar
  24. 24.
    Christmanson L, Rorsman F, Stenman G, Westermark P, Betsholtz C (1990) The human islet amyloid polypeptide (IAPP) gene. Organization, chromosomal localization and functional identification of a promoter region. FEBS Lett 267: 160–166Google Scholar
  25. 25.
    van Mansfeld ADM, Mosselman S, Höppener JWM et al. (1990) Islet amyloid polypeptide: structure and upstream sequences of the IAPP genes in rat and man. Biochim Biophys Acta 1087: 235–240Google Scholar
  26. 26.
    Mosselman S, Höppener JWM, Zandberg J et al. (1988) Islet amyloid polypeptide: identification and chromosomal localization of the human gene. FEBS Lett 239: 227–232Google Scholar
  27. 27.
    Cooper GJS, Day AJ, Willis AC, Roberts AN, Reid KBM, Leighton B (1989) Amylin and the amylin gene: structure, function and relationship to islet amyloid and to diabetes mellitus. Biochim Biophys Acta 1014: 247–258Google Scholar
  28. 28.
    Madsen O, Nielsen JH, Michelsen B et al. (1991) Islet amyloid polypeptide (IAPP/amylin) and insulin expression are controlled differently in primary and transformed islet cells. Mol Endocrinol 5: 143–148Google Scholar
  29. 29.
    Ferrier GJM, Pierson AM, Jones PM, Bloom SR, Girgis SI, Legon S (1989) Expression of the rat amylin (IAPP/DAP) gene. J Endocrinol 3: R1-R4Google Scholar
  30. 30.
    Nakazato M, Asai J, Kangawa K, Matsukura S, Matsuo H (1989) Establishment of radioimmunoassay for human islet amyloid polypeptide and its tissue content and plasma concentration. Biochem Biophys Res Commun 164: 394–399Google Scholar
  31. 31.
    Asai J, Nakazato M, Miyazato M, Kangawa K, Matsuo H, Matsukura S (1990) Regional distribution and molecular forms of rat islet amyloid polypeptide. Biochem Biophys Res Commun 169: 788–795Google Scholar
  32. 32.
    Toshimori H, Narita R, Nakazato M et al. (1990) Islet amyloid polypeptide (IAPP) in the gastrointestinal tract and pancreas of man and rat. Cell Tissue Res 262: 401–406Google Scholar
  33. 33.
    Leffert JD, Newgard CB, Okamoto H, Milburn JL, Luskey KL (1989) Rat amylin: cloning and tissue-specific expression in pancreatic islets. Proc Natl Acad Sci USA 86: 3127–3130Google Scholar
  34. 34.
    Johnson KH, O'Brien TD, Hayden DW, Mahoney WC, Wernstedt C, Westermark P (1988) Relationships of islet amyloid polypeptide (IAPP) to spontaneous diabetes in adult cats. In: Isobe T, Araki S, Uchino F, Kito S, Tsubura E (eds) Amyloid and Amyloidosis. Plenum Press, New York, pp 673–678Google Scholar
  35. 35.
    Kanatsuka A, Makino H, Ohsawa H et al. (1989) Secretion of islet amyloid polypeptide in response to glucose. FEBS Lett 259: 199–201Google Scholar
  36. 36.
    Nakazato M, Miyazato M, Asai J et al. (1990) Islet amyloid polypeptide, a novel pancreatic peptide, is a circulating hormone secreted under glucose stimulation. Biochem Biophys Res Commun 169: 713–718Google Scholar
  37. 37.
    Sanke T, Hanabusa T, Nakano Y et al. (1991) Plasma islet amyloid polypeptide (amylin) levels and their responses to oral glucose in Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 34: 129–132Google Scholar
  38. 38.
    Hartter E, Svoboda T, Ludvik B et al. (1991) Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans. Diabetologia 34: 52–54Google Scholar
  39. 39.
    Fehmann HC, Weber V, Göke R, Göke B, Arnold R (1990) Cosecretion of amylin and insulin from isolated rat pancreas. FEBS Lett 262: 279–281Google Scholar
  40. 40.
    Butler P, Chou J, Carter WB et al. (1990) Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes 39: 752–756Google Scholar
  41. 41.
    Inoue K, Hisatomi A, Umeda F, Nawata H (1990) Amylin release from perfused rat pancreas in response to glucose and arginine. Diab Res Clin Pract 10: 189–192Google Scholar
  42. 42.
    Mitsukawa T, Takemura J, Asai J et al. (1990) Islet amyloid polypeptide response to glucose, insulin, and somatostatin analogue administration. Diabetes 39: 639–642Google Scholar
  43. 43.
    Kahn SE, D'Alessio DA, Schwartz MW et al. (1990) Evidence of cosecretion of islet amyloid polypeptide and insulin by β-cells. Diabetes 39: 634–638Google Scholar
  44. 44.
    Bretherton-Watt D, Ghatei MA, Jamal H et al. (1989) Altered islet amyloid polypeptide (IAPP) gene expression in rat models of diabetes. Diabetologia 32: 881–883Google Scholar
  45. 45.
    O'Brien TD, Westermark P, Johnson KH (1991) Islet amyloid polypeptide and insulin secretion from isolated perfused pancreas of fed, fasted, glucose-treated and dexamethasone-treated rats. Diabetes 40: 1701–1706Google Scholar
  46. 46.
    van Jaarsveld BC, Hackeng WHL, Niewenhuis MG, Erkelens DW, Geerdink RA, Lips CJM (1990) Islet amyloid polypeptide in human plasma. Lancet I: 60Google Scholar
  47. 47.
    Bretherton-Watt D, Gilbey SG, Ghatei MA, Beacham J, Bloom SR (1990) Failure to establish islet amyloid polypeptide (amylin) as a circulating Beta-cell inhibiting hormone in man. Diabetologia 33: 115–117Google Scholar
  48. 48.
    Westermark P, Johnson KH (1988) The pathogenesis of maturity-onset diabetes mellitus: is there a link to islet amyloid polypeptide? BioEssays 9: 30–33Google Scholar
  49. 49.
    Westermark P, Wilander E, Westermark GT, Johnson KH (1987) Islet amyloid polypeptide-like immunoreactivity in the islet B cells of Type 2 (non-insulin-dependent) diabetic and non-diabetic individuals. Diabetologia 30: 887–892Google Scholar
  50. 50.
    Johnson KH, O'Brien TD, Jordan K, Westermark P (1989) Impaired glucose tolerance is associated with increased islet amyloid polypeptide (IAPP) immunoreactivity in pancreatic beta cells. Am J Pathol 135: 245–250Google Scholar
  51. 51.
    Gill AM, Yen TT (1991) Effects of ciglitazone on endogenous plasma islet amyloid polypeptide and insulin sensitivity in obese-diabetic viable yellow mice. Life Sci 48: 703–710Google Scholar
  52. 52.
    Ogawa A, Harris V, McCorkie SK, Unger RH, Luskey KL (1990) Amylin secretion from the rat pancreas and its selective loss after streptozotocin treatment. J Clin Invest 85: 973–976Google Scholar
  53. 53.
    Jamal H, Bretherton-Watt D, Suda K, Ghatei MA, Bloom SR (1990) Islet amyloid polypeptide-like immunoreactivity (amylin) in rats treated with dexamethasone and streptozotocin. J Endocrinol 126: 425–429Google Scholar
  54. 54.
    Ohsawa H, Kanatsuka A, Yamaguchi T, Makino H, Yoshida S (1989) Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic islets. Biochem Biophys Res Commun 160: 961–967Google Scholar
  55. 55.
    Silvestre RA, Peiró E, D'gano P, Miralles P, Marco J (1990) Inhibitory effect of rat amylin on the insulin responses to glucose and arginine in the perfused rat pancreas. Regul Pept 31: 23–31Google Scholar
  56. 56.
    Ghatei MA, Datta HK, Zaidi M et al. (1990) Amylin and amylinamide lack an acute effect on blood glucose and insulin. J Endocrinol 124: R9-R11Google Scholar
  57. 57.
    Nagamatsu S, Carrol RJ, Grodsky GM, Steiner DF (1990) Lack of islet amyloid polypeptide regulation of insulin biosynthesis or secretion in normal rat islets. Diabetes 39: 871–874Google Scholar
  58. 58.
    O'Brien TD, Westermark P, Johnson KH (1990) Islet amyloid polypeptide (IAPP) does not inhibit glucose-stimulated insulin secretion from isolated perfused rat pancreas. Biochem Biophys Res Commun 170: 1223–1228Google Scholar
  59. 59.
    Fehmann H-C, Weber V, Göke R, Göke B, Eissele R, Arnold R (1990) Islet amyloid polypeptide (IAPP; amylin) influences the endocrine but not the exocrine rat pancreas. Biochem Biophys Res Commun 167: 1102–1108Google Scholar
  60. 60.
    Pettersson M, Ahrén B (1988) Insulin and glucagon secretion in rats: effects of calcitonin gene-related peptide. Regul Pept 23: 37–50Google Scholar
  61. 61.
    Johnson KH, O'Brien TD, Jordan K, Betsholtz C, Westermark P (1990) The putative hormone islet amyloid polypeptide (IAPP) induces impaired glucose tolerance in cats. Biochem Biophys Res Commun 167: 507–513Google Scholar
  62. 62.
    Sowa R, Sanke T, Hirayama J et al. (1990) Islet amyloid polypeptide amide causes peripheral insulin resistance in vivo in dogs. Diabetologia 33: 118–120Google Scholar
  63. 63.
    Frontoni S, Bong Choi S, Banduch D, Rossetti L (1991) In vivo insulin resistance induced by amylin primarily through inhibition of insulin-stimulated glycogen synthesis in skeletal muscle. Diabetes 40: 568–573Google Scholar
  64. 64.
    Koopmans SJ, van Mansfeld ADM, Jansz HS et al. (1991) Amylin-induced in vivo resistance in conscious rats: the liver is more sensitive to amylin than peripheral tissues. Diabetologia 34: 218–224Google Scholar
  65. 65.
    Leighton B, Cooper GJS (1988) Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature 335: 632–635Google Scholar
  66. 66.
    Leighton B, Foot E (1990) The effects of amylin on carbohydrate metabolism in skeletal muscle in vitro and in vivo. Biochem J 269: 19–23Google Scholar
  67. 67.
    Hothersall JS, Muirhead RP, Wimalawansa S (1990) The effect of amylin and calcitonin gene-related peptide on insulin-stimulated glucose transport in the diaphragm. Biochem Biophys Res Commun 169: 451–454Google Scholar
  68. 68.
    Zierath JR, Galuska D, Engström Å et al. (1992) Human islet amyloid polypeptide at pharmacological levels inhibits insulin and phorbol ester-stimulated glucose transport in in vitro incubated human muscle strips. Diabetologia 35: 26–31Google Scholar
  69. 69.
    Deems RO, Deacon RW, Young DA (1991) Amylin activates glycogen phosphorylase and inactivates glycogen synthase via a cAMP-independent mechanism. Biochem Biophys Res Commun 174: 716–720Google Scholar
  70. 70.
    Young AA, Mott DM, Stone K, Cooper GJS (1991) Amylin activates glycogen phosphorylase in the isolated soleus muscle of the rat. FEBS Lett 281: 149–151Google Scholar
  71. 71.
    Morishita T, Yamaguchi A, Fujita T, Chiba T (1990) Activation of adenylate cyclase by islet amyloid polypeptide with COOH-terminal amide via calcitonin gene-related peptide receptors on rat liver plasma membranes. Diabetes 39: 875–877Google Scholar
  72. 72.
    Galeuzza MT, O'Brien TD, Johnson KH, Seybold KS (1991) Islet amyloid polypeptide (IAPP) competes for two binding sites of CGRP. Peptides 12: 585–591Google Scholar
  73. 73.
    Stephens TW, Heath WF, Hermeling RN (1991) Presence of liver CGRP/Amylin receptors in only nonparenchymal cells and absence of direct regulation of rat liver glucose metabolism by CGRP/amylin. Diabetes 40: 395–400Google Scholar
  74. 74.
    Datta HK, Zaidi M, Wimlawansa SJ et al. (1989) In vivo and in vitro effects of amylin and amylin-amide on calcium metabolism in the rat and rabbit. Biochem Biophys Res Commun 162: 876–881Google Scholar
  75. 75.
    Brain SD, Wimalawansa S, MacIntyre I, Williams TJ (1990) The demonstration of vasodilator activity of pancreatic amylin amide in the rabbit. Am J Pathol 136: 487–490Google Scholar
  76. 76.
    Chance WT, Balasubramaniam A, Zhang FS, Wimalawansa SJ, Fischer JE (1991) Anorexia following the intrahypothalamic administration of amylin. Brain Res 539: 352–354Google Scholar
  77. 77.
    Nishi M, Bell GI, Steiner DF (1990) Islet amyloid polypeptide (amylin): no evidence of an abnormal precursor sequence in 25 Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 33: 628–630Google Scholar
  78. 78.
    Westermark P, Engström U, Johnson KH, Westermark GT, Betsholtz C (1990) Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci USA 87: 5036–5040Google Scholar
  79. 79.
    Breeze AL, Harvey TS, Bazzo R, Campbell ID (1991) Solution structure of human calcitonin gene-related peptide by 1H NMR and distance geometry with restrained molecular dynamics. Biochemistry 30: 575–582Google Scholar
  80. 80.
    Glenner GG, Eanes ED, Wiley CA (1988) Amyloid fibril formed from a segment of the pancreatic islet amyloid protein. Biochem Biophys Res Commun 155: 608–614Google Scholar
  81. 81.
    Westermark P, Johnson KH, Engström U, Westermark GT, Betsholtz C (1991) Islet amyloid polypeptide: synthetic peptides for study of the pathogenesis of islet amyloid. In: Natvig JB, Förre Ö, Husby G et al. (eds) Amyloid and amyloidosis 1990. Kluwer Academic Publishers. Dordrecht, pp 449–452Google Scholar
  82. 82.
    Betsholtz C, Johnson KH, Westermark P (1989) “Amylin” hormone. Nature 338: 211Google Scholar
  83. 83.
    Johnson KH, Wernstedt C, O'Brien TD, Westermark P (1991) Amyloid in the pancreatic islets of the cougar (Felis concolor) is derived from islet amyloid polypeptide (IAPP). Comp Biochem Physiol 98B: 115–119Google Scholar
  84. 84.
    Jordan K, Murtaugh MP, O'Brien TD, Westermark P, Betsholtz C, Johnson KH (1990) Canine IAPP cDNA sequence provides important clues regarding diabetogenesis and amyloidogenesis in type 2 diabetes. Biochem Biophys Res Commun 169: 502–508Google Scholar
  85. 85.
    O'Brien TD, Westermark P, Johnson KH (1990) Islet amyloid polypeptide and calcitonin gene-related peptide immunoreactivity in amyloid and tumor cells of canine pancreatic endocrine tumors. Vet Pathol 27: 194–198Google Scholar
  86. 86.
    Westermark P, Engström U, Westermark GT, Johnson KH, Permerth J, Betsholtz C (1989) Islet amyloid polypeptide (IAPP) and pro-IAPP immunoreactivity in human islets of Langerhans. Diab Res Clin Pract 7: 219–226Google Scholar
  87. 87.
    Cook JTE, Patel PP, Clark A et al. (1991) Non-linkage of the islet amyloid polypeptide gene with Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34: 103–108Google Scholar
  88. 88.
    Nakazato M, Asai J, Miyazato M, Matsukura S, Kangawa K, Matsuo H (1990) Isolation and identification of islet amyloid polypeptide in normal human pancreas. Regul Pept 31: 179–186Google Scholar
  89. 89.
    Westermark P, Wilander E (1978) The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia 15: 417–421Google Scholar
  90. 90.
    Howard CF Jr (1978) Insular amyloidosis and diabetes mellitus in Macaca nigra. Diabetes 27: 357–364Google Scholar
  91. 91.
    Maloy AL, Longnecker DS, Greenberg ER (1981) The relation of islet amyloid to the clinical type of diabetes. Hum Pathol 12: 917–922Google Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • P. Westermark
    • 1
  • K. H. Johnson
    • 3
  • T. D. O'Brien
    • 3
  • C. Betsholtz
    • 2
  1. 1.Department of PathologyUniversity of LinköpingSweden
  2. 2.Department of PathologyUniversity of UppsalaSweden
  3. 3.Department of Veterinary Pathobiology, College of Veterinary MedicineUniversity of MinnesotaMinneapolisUSA

Personalised recommendations